AU1649700A - Novel formulation - Google Patents

Novel formulation

Info

Publication number
AU1649700A
AU1649700A AU16497/00A AU1649700A AU1649700A AU 1649700 A AU1649700 A AU 1649700A AU 16497/00 A AU16497/00 A AU 16497/00A AU 1649700 A AU1649700 A AU 1649700A AU 1649700 A AU1649700 A AU 1649700A
Authority
AU
Australia
Prior art keywords
novel formulation
formulation
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16497/00A
Other languages
English (en)
Inventor
Tina Meinertz Andersen
Thyge Borup Hjorth
Kim Westi Jorgensen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU1649700A publication Critical patent/AU1649700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU16497/00A 1998-12-22 1999-12-14 Novel formulation Abandoned AU1649700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA199801703 1998-12-22
DKPA199801703 1998-12-22
PCT/DK1999/000699 WO2000037081A1 (fr) 1998-12-22 1999-12-14 Nouvelle formulation

Publications (1)

Publication Number Publication Date
AU1649700A true AU1649700A (en) 2000-07-12

Family

ID=8107354

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16497/00A Abandoned AU1649700A (en) 1998-12-22 1999-12-14 Novel formulation

Country Status (4)

Country Link
EP (1) EP1140084A1 (fr)
JP (1) JP2002532551A (fr)
AU (1) AU1649700A (fr)
WO (1) WO2000037081A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6723340B2 (en) * 2001-10-25 2004-04-20 Depomed, Inc. Optimal polymer mixtures for gastric retentive tablets
MY152185A (en) * 2005-06-10 2014-08-29 Novartis Ag Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation
CN114533699B (zh) * 2021-12-15 2023-05-26 南通联亚药业股份有限公司 一种盐酸环苯扎林缓释胶囊及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4680323A (en) * 1983-12-01 1987-07-14 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
MY113463A (en) * 1994-01-04 2002-03-30 Novo Nordisk As Novel heterocyclic compounds
PL327445A1 (en) * 1995-12-15 1998-12-07 Novo Nordisk As Novel process
US5783212A (en) * 1996-02-02 1998-07-21 Temple University--of the Commonwealth System of Higher Education Controlled release drug delivery system

Also Published As

Publication number Publication date
EP1140084A1 (fr) 2001-10-10
WO2000037081A1 (fr) 2000-06-29
JP2002532551A (ja) 2002-10-02

Similar Documents

Publication Publication Date Title
AU3485999A (en) Neo-tryptophan
AU2623899A (en) Novel thiobenzamides
AU9392998A (en) Pack-a-pillow
AU2350199A (en) Novel aminoorganofunctionalsiloxanes
AUPP650198A0 (en) Cement formulation
AU5575398A (en) Hairdye compositions
AU3522399A (en) Carvedilol-galenics
AU3437799A (en) City-car
AU4037699A (en) Novel aryl-hydro naphthalenal kanamines
AU5407599A (en) Sphingolipid-desaturase
AU3253699A (en) Myxochelines
AU8363398A (en) Capotasto
AU5378599A (en) Oral formulation
AU6217199A (en) Compositions
GB9810180D0 (en) Novel formulation
AU2609599A (en) Sensor-coupling
AU2724799A (en) Novel endo-xylogalacturonase
AU3204999A (en) Futureball
AU2069199A (en) Codelets
AU1649700A (en) Novel formulation
AUPP053197A0 (en) Compositions
AU1055399A (en) Rollerboard
AU5223199A (en) Bathtub-bathseat
AU2648899A (en) Composition
AU1137300A (en) Cement formulation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase